6499.TWO - Medeon Biodesign, Inc.

Taipei Exchange - Taipei Exchange Delayed Price. Currency in TWD
Currency in TWD

Valuation Measures

Market Cap (intraday) 54.45B
Enterprise Value 32.94B
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)12.70
Price/Book (mrq)2.10
Enterprise Value/Revenue 38.41
Enterprise Value/EBITDA 6-16.34

Trading Information

Stock Price History

Beta (3Y Monthly) 1.26
52-Week Change 3-42.20%
S&P500 52-Week Change 31.35%
52 Week High 3119.95
52 Week Low 365.50
50-Day Moving Average 374.92
200-Day Moving Average 378.79

Share Statistics

Avg Vol (3 month) 326.8k
Avg Vol (10 day) 327.36k
Shares Outstanding 566.48M
Float N/A
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21000/1099
Last Split Date 3Jul 5, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin -57.04%
Operating Margin (ttm)-69.68%

Management Effectiveness

Return on Assets (ttm)-6.50%
Return on Equity (ttm)-10.95%

Income Statement

Revenue (ttm)350.1M
Revenue Per Share (ttm)5.71
Quarterly Revenue Growth (yoy)81.20%
Gross Profit (ttm)481.12M
EBITDA -180.17M
Net Income Avi to Common (ttm)-199.7M
Diluted EPS (ttm)-3.26
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.93B
Total Cash Per Share (mrq)29.02
Total Debt (mrq)125.24M
Total Debt/Equity (mrq)5.30
Current Ratio (mrq)11.65
Book Value Per Share (mrq)31.92

Cash Flow Statement

Operating Cash Flow (ttm)-208.08M
Levered Free Cash Flow (ttm)-81.64M